24 Jan Guideline for Pre-Registration Consultation Meeting
Posted at 12:47h
in
This document provides guidance on the procedures involved in the scheduling and conduct of Pre-Registration Consultation meetings between the Office of the Chief Regulatory Authority (CRO) of the South African Health Product Regulatory Authority (SAHPRA), and the applicant / sponsor for biological medicines. The primary purpose of the meetings is to address issues relating to the development of biological medicines in the planning phase of such products.
Download latest version
Download archived version
Download archived version
Document Number:
SAHPGL-PEM-BIO-03
Version:
2
Date Updated:
13/09/2022
File Type:
pdf
Category:
Guideline